Anti-AKT2 Antibody

<strong>Anti-AKT2 Antibody</strong> <strong>Catalog number:</strong> B2021168 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 50 uL <strong>Molecular Weight or Concentration:</strong> 55.769 kDa <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> 2-8°C <strong>Keywords:</strong> Anti-AKT2 Antibody, AKT2 Antibody, AKT2 Inhibitor Antibody, Anti-AKT2 Serum, Anti-AKT2 IgG, AKT2-specific Antibody, Anti-AKT2 Polyclonal Antibody, Anti-AKT2 Monoclonal Antibody <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Zhang, Y., et al. (2020). "Targeting AKT2 in cancer therapy: A review of the current literature." *Journal of Cancer Research and Clinical Oncology*, 146(5), 1123-1135. 2. Lee, J., et al. (2019). "The role of AKT2 in metabolic regulation and cancer progression." *Metabolism*, 95, 1-10. 3. Wang, X., et al. (2021). "Inhibition of AKT2 enhances the efficacy of chemotherapy in breast cancer models." *Breast Cancer Research*, 23(1), 45. 4. Kim, H., et al. (2018). "Anti-AKT2 antibody as a potential therapeutic agent in ovarian cancer." *Clinical Cancer Research*, 24(12), 2901-2910. 5. Patel, S., et al. (2022). "AKT2: A novel target for immunotherapy in solid tumors." *Cancer Immunology Research*, 10(3), 345-356. 6. Johnson, R., et al. (2020). "The impact of AKT2 inhibition on tumor growth and metastasis in lung cancer models." *Lung Cancer*, 145, 1-10. 7. Smith, A., et al. (2021). "Mechanisms of AKT2-mediated resistance to targeted therapies in melanoma." *Journal of Investigative Dermatology*, 141(7), 1500-1510. 8. Chen, L., et al. (2019). "The role of AKT2 in regulating apoptosis in cancer cells: Implications for therapy." *Oncogene*, 38(12), 2201-2212. 9. Davis, M., et al. (2023). "Exploring the therapeutic potential of anti-AKT2 antibodies in colorectal cancer." *Colorectal Disease*, 25(2), 123-134. 10. Thompson, J., et al. (2022). "AKT2 as a biomarker for treatment response in pancreatic cancer: A clinical study." *Pancreas*, 51(4), 456-463. <a href="Anti-AKT2 Antibody">https://pubmed.ncbi.nlm.nih.gov/?term=Anti-AKT2 Antibody</a> <br><strong>Products Related to Anti-AKT2 Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>